» Articles » PMID: 38656031

Bilateral Acute Depigmentation of the Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT): A Case Series from a Center in Brazil

Overview
Specialty Ophthalmology
Date 2024 Apr 24
PMID 38656031
Authors
Affiliations
Soon will be listed here.
Abstract

Bilateral acute depigmentation of the iris and bilateral acute iris transillumination (BAIT) are similar clinical entities. The former causes acute-onset depigmentation of the iris stroma without transillumination, whereas the latter causes depigmentation of the iris pigment epithelium with transillumination. The etiopathogenesis of these conditions is not yet fully understood, but the proposed causes include the use of systemic antibiotics (especially moxifloxacin) and viral triggers. We present a case series of five female patients with a mean age of 41 (32-45) years, all of whom suffered acute onset of bilateral pain and redness of the eyes after moxifloxacin use (oral or topical). It is important for ophthalmologists to be aware of the two forms of iris depigmentation since this case series suggests that SARS-CoV-2 or its empirical treatment with moxifloxacin may trigger iris depigmentation. If this is the case, clinicians will likely see increased incidences of bilateral acute depigmentation of the iris and bilateral acute iris transillumination during and after the COVID-19 pandemic.

References
1.
Tugal-Tutkun I, Altan C . Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-An Update. Turk J Ophthalmol. 2022; 52(5):342-347. PMC: 9631498. DOI: 10.4274/tjo.galenos.2022.09552. View

2.
Behndig A, Cochener-Lamard B, Guell J, Kodjikian L, Mencucci R, Nuijts R . Surgical, antiseptic, and antibiotic practice in cataract surgery: Results from the European Observatory in 2013. J Cataract Refract Surg. 2016; 41(12):2635-43. DOI: 10.1016/j.jcrs.2015.06.031. View

3.
Tugal-Tutkun I, Onal S, Garip A, Taskapili M, Kazokoglu H, Kadayifcilar S . Bilateral acute iris transillumination. Arch Ophthalmol. 2011; 129(10):1312-9. DOI: 10.1001/archophthalmol.2011.310. View

4.
Tugal-Tutkun I, Urgancioglu M . Bilateral acute depigmentation of the iris. Graefes Arch Clin Exp Ophthalmol. 2005; 244(6):742-6. DOI: 10.1007/s00417-005-0137-x. View

5.
Hinkle D . Re-assessing Evidence for Adverse Ocular Reactions Associated with Fluoroquinolones: Implications for Intracameral Use. Ocul Immunol Inflamm. 2020; 30(1):208-209. DOI: 10.1080/09273948.2020.1775857. View